VERA EBITDA Growth

Vera Therapeutics Inc Class A · EBITDA Growth

VERA logo

VERA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-87.07%
VERA TTM EBITDA YoY % (35.70% → -87.07%)
High-resolution chart · PNG

VERA ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vera Therapeutics Inc Class A EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-87.0671%
-115.0994%
-101.9264%
-87.6207%
-101.3379%
-83.327%
-52.4222%
-30.8889%
0.1871%
9.1709%
-7.6559%
-36.1229%
-86.9728%
-125.4436%
-171.5352%
-29.1389%
-6.3043%
15.2749%
35.7048%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.